Adjuvant therapy in type 1 diabetes mellitus

Adjuvant therapy in type 1 diabetes mellitus — choice or necessity in the COVID-19 pandemic?

“…A paper on the use of adjuvant therapy in type 1 diabetes was published in the previous issue of Endokrynologia Polska [1]. The search for new therapeutic options in patients with type 1 diabetes is the result of the increasing incidence of metabolic disorders in this group of patients, including obesity and, paradoxically, insulin resistance, which is particularly evident during the COVID-19 pandemic.…”